Table 2 Perioperative outcomes and pathological results of the studies
ID | Treatment type | Urinary diversion | BLV (ml) | OT (h) | PSM, n(%) | PLN, n(%) | SVI, n(%) | BI, n(%) | Gleason score | Overestimated T stage, n(%) | Underestimated T stage, n(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Salvage | Ileal conduit: 1 Koch Pouch: 3 | 5000 | 9.4 | 1(25%) | 0 | 1 (25%) | 1 (25%) | 7.6 | 0 | 0 |
Primary | Ileal conduit: 8 Koch Pouch: 1 | 2700 | 7.8 | 7(78%) | 9(100%) | 5 (55.6%) | 2 (22.2%) | 7.4 | 4 (44.4%) | 0 | |
2 | Salvage | Orthotopic neobladder: 2 Ileal conduit: 3 | Nx | Nx | 3(60%) | 2(40%) | 5 (100%) | 0 | 8.2 | 2 (40%) | 3 (60%) |
3 | Primary | Orthotopic neobladder: 8 Ileal conduit: 5 Koch Pouch: 1 Ureterocutaneostomy: 1 | Nx | Nx | Nx | Nx | 9 (60%) | 6 (40%) | Nx | 9 (60%) | 0 |
4 | Salvage | Orthotopic neobladder: 1 Ileal conduit: 29 Indiana Pouch: 8 | 2100 | Nx | 11 (52%) | 1 (4.7%) | 37(97.4%) | 33 (86.8%) | Nx | 5 (13.2%) | 0 |
Primary | 5 (29%) | 4 (23.5%) | |||||||||
5 | Salvage | Nx | Nx | Nx | 20 (33%) | Nx | Nx | Nx | Nx | 22 (36%) | 0 |
6 | Primary | Orthotopic neobladder: 9 Ileal conduit : 7 Koch Pouch: 1 | Nx | Nx | Nx | 10 (58.8%) | 13 (76.5%) | 14 (82.4%) | 9.1 | 3 (17.6%) | Nx |
7 | Primary | Nx | Nx | Nx | 33 (53%) | 30 (48.4%) | 41 (66.1%) | Nx | Nx | 9 (14.5%) | 0 |